Injectable Paromomycin for Visceral Leishmaniasis in India

2007462 citationsJournal Article

Authors

Shyam Sundar · Institute of Medical Sciences

Chandreshwar Prasad Thakur · Balaji Utthan Sansthan

Prabhat Kumar Sinha · Rajendra Memorial Research Institute of Medical Sciences

Sujit Bhattacharya · Rajendra Memorial Research Institute of Medical Sciences

Abstract

Paromomycin was shown to be noninferior to amphotericin B for the treatment of visceral leishmaniasis in India. (ClinicalTrials.gov number, NCT00216346.)

Topics & Keywords

Research on Leishmaniasis Studies Synthesis and Biological Evaluation Trypanosoma species research and implications

UN Sustainable Development Goals

No poverty

Publication Details

Published in: New England Journal of Medicine

Volume 356, Issue 25, pp. 2571-2581

DOI: 10.1056/nejmoa066536

Field-Weighted Citation Impact: 36.28